Silverfin false false 31/12/2024 14/02/2024 31/12/2024 Dr J F McAleer 14/02/2024 Dr D Scott 14/02/2024 Mr R Zwanziger 14/02/2024 11 September 2025 The principal activity of the Company during the financial period was the research and development of biotechnology. 15489988 2024-12-31 15489988 bus:Director1 2024-12-31 15489988 bus:Director2 2024-12-31 15489988 bus:Director3 2024-12-31 15489988 core:CurrentFinancialInstruments 2024-12-31 15489988 core:ShareCapital 2024-12-31 15489988 core:RetainedEarningsAccumulatedLosses 2024-12-31 15489988 core:LeaseholdImprovements 2024-02-13 15489988 core:PlantMachinery 2024-02-13 15489988 core:OfficeEquipment 2024-02-13 15489988 core:ComputerEquipment 2024-02-13 15489988 2024-02-13 15489988 core:LeaseholdImprovements 2024-12-31 15489988 core:PlantMachinery 2024-12-31 15489988 core:OfficeEquipment 2024-12-31 15489988 core:ComputerEquipment 2024-12-31 15489988 core:ImmediateParent core:CurrentFinancialInstruments 2024-12-31 15489988 bus:OrdinaryShareClass1 2024-12-31 15489988 2024-02-14 2024-12-31 15489988 bus:FilletedAccounts 2024-02-14 2024-12-31 15489988 bus:SmallEntities 2024-02-14 2024-12-31 15489988 bus:AuditExemptWithAccountantsReport 2024-02-14 2024-12-31 15489988 bus:PrivateLimitedCompanyLtd 2024-02-14 2024-12-31 15489988 bus:Director1 2024-02-14 2024-12-31 15489988 bus:Director2 2024-02-14 2024-12-31 15489988 bus:Director3 2024-02-14 2024-12-31 15489988 core:LeaseholdImprovements core:TopRangeValue 2024-02-14 2024-12-31 15489988 core:PlantMachinery core:TopRangeValue 2024-02-14 2024-12-31 15489988 core:OfficeEquipment core:TopRangeValue 2024-02-14 2024-12-31 15489988 core:ComputerEquipment core:TopRangeValue 2024-02-14 2024-12-31 15489988 core:LeaseholdImprovements 2024-02-14 2024-12-31 15489988 core:PlantMachinery 2024-02-14 2024-12-31 15489988 core:OfficeEquipment 2024-02-14 2024-12-31 15489988 core:ComputerEquipment 2024-02-14 2024-12-31 15489988 bus:OrdinaryShareClass1 2024-02-14 2024-12-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 15489988 (England and Wales)

ELECTRADX UK LTD

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 14 FEBRUARY 2024 TO 31 DECEMBER 2024
PAGES FOR FILING WITH THE REGISTRAR

ELECTRADX UK LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL PERIOD FROM 14 FEBRUARY 2024 TO 31 DECEMBER 2024

Contents

ELECTRADX UK LTD

BALANCE SHEET

AS AT 31 DECEMBER 2024
ELECTRADX UK LTD

BALANCE SHEET (continued)

AS AT 31 DECEMBER 2024
Note 31.12.2024
£
Fixed assets
Tangible assets 3 380,207
380,207
Current assets
Debtors 4 690,168
Cash at bank and in hand 392,428
1,082,596
Creditors: amounts falling due within one year 5 ( 3,787,371)
Net current liabilities (2,704,775)
Total assets less current liabilities (2,324,568)
Net liabilities ( 2,324,568)
Capital and reserves
Called-up share capital 6 1
Profit and loss account ( 2,324,569 )
Total shareholder's deficit ( 2,324,568)

For the financial period ending 31 December 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Electradx UK Ltd (registered number: 15489988) were approved and authorised for issue by the Board of Directors on 11 September 2025. They were signed on its behalf by:

Dr D Scott
Director
ELECTRADX UK LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL PERIOD FROM 14 FEBRUARY 2024 TO 31 DECEMBER 2024
ELECTRADX UK LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL PERIOD FROM 14 FEBRUARY 2024 TO 31 DECEMBER 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.

General information and basis of accounting

Electradx UK Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 48 Chancery Lane, London, WC2A 1JF, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors note that the business has net liabilities of £2,324,568. The Company is supported through loans from the Parent Company. The directors have received assurances that the loan facilities will continue to be available for at least 12 months from the date of signing these financial statements and the Parent Company will continue to support the Company. After making enquiries, the directors believe that any foreseeable debts can be met for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Profit and Loss Account in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Employee benefits

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Profit and Loss Account in respect of pension costs and other post-retirement benefits is the contributions payable in the financial period. Differences between contributions payable in the financial period and contributions actually paid are included as either accruals or prepayments in the Balance Sheet.

Tangible fixed assets

Tangible fixed assets are stated at cost net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset on a straight-line basis over its expected useful life, as follows:

Leasehold improvements 4 years straight line
Plant and machinery 4 years straight line
Office equipment 4 years straight line
Computer equipment 4 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Leases

The Company as lessee
Assets held under finance leases, hire purchase contracts and other similar arrangements, which confer rights and obligations similar to those attached to owned assets, are capitalised as tangible fixed assets at the fair value of the leased asset (or, if lower, the present value of the minimum lease payments as determined at the inception of the lease) and are depreciated over the shorter of the lease terms and their useful lives. The capital elements of future lease obligations are recorded as liabilities, while the interest elements are charged to the Profit and Loss Account over the period of the leases to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.

Impairment of assets

Assets are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

2. Employees

Period from
14.02.2024 to
31.12.2024
Number
Monthly average number of persons employed by the Company during the period, including directors 9

3. Tangible assets

Leasehold improve-
ments
Plant and machinery Office equipment Computer equipment Total
£ £ £ £ £
Cost
At 14 February 2024 0 0 0 0 0
Additions 73,051 339,502 3,075 22,525 438,153
At 31 December 2024 73,051 339,502 3,075 22,525 438,153
Accumulated depreciation
At 14 February 2024 0 0 0 0 0
Charge for the financial period 3,044 51,883 145 2,874 57,946
At 31 December 2024 3,044 51,883 145 2,874 57,946
Net book value
At 31 December 2024 70,007 287,619 2,930 19,651 380,207

4. Debtors

31.12.2024
£
Corporation tax 301,391
Other debtors 388,777
690,168

5. Creditors: amounts falling due within one year

31.12.2024
£
Trade creditors 251,579
Amounts owed to Parent undertakings 3,328,126
Other creditors 207,666
3,787,371

6. Called-up share capital

31.12.2024
£
Allotted, called-up and fully-paid
1 Ordinary share of £ 1.00 1